Abstract:AIM:Point mutation, one of the commonest gene mutations, is the most important molecular pathogenesis of cancer and chronic infection. The commonest methods for detection of point mutation are based on polymerase chain reaction (PCR). These techniques, however, cannot be used in large scale screening since they are neither accurate nor simple. For this reason, this study established a novel method of competitively differentiated PCR (CD-PCR) for screening point mutation in clinical practice.METHODS:Two competitively differentiated primers for mutant-type and wild-type templates respectively with an identically complemented region in 3' end except for last 2 base pairs and a different non-complemented region in 5' end were designed. Thus, competitive amplification might be carried out at a lower annealing temperature at first, and then differentiated amplification at a higher annealing temperature when primers could not combine with initial templates. The amplification was performed in one-tube. The products of CD-PCR were detected using microplate hybridization assay. CD-PCR was evaluated by detecting G1896A variant of hepatitis B virus (HBV) in form of recombinant plasmids and in sera from patients with hepatitis B, and compared with allele-specific PCR (AS-PCR) and competitive AS-PCR.RESULTS:CD-PCR was successfully established. It could clearly distinguish wild-type and mutant-type plasmid DNA of G1896A variant when the amount of plasmid DNA was between 10(2)-10(8)copies/reaction, while for AS-PCR and competitive AS-PCR, the DNA amount was between 10(2)-10(4)copies/reaction. CD-PCR could detect one copy of G1896A variant among 10-100 copies of wild-type plasmid DNA. The specificity of CD-PCR was higher than those of AS-PCR and competitive AS-PCR in the detection of HBV G1896A variant in sera from patients with hepatitis B. CD-PCR was independent of the amount of HBV DNA in serum. HBV G1896A variant was more often found in HBeAg (-) patients with a lower level of detectable viremia than that with a higher level of detectable viremia (P=0.0192).CONCLUSION:CD-PCR is more specific since it is less influenced by the amount of initial templates and the cross amplification between mutant- and wild-type amplified products. It is also simple and time-saving. Thus, CD-PCR might be useful in routine gene typing and point mutation screening. HBV G1896A or other more important mutations have to be routinely detected in patients with a detectable level of viremia after HBeAg/antibody conversion in clinical practice.

An enzyme-linked hybridization on microplate for quantification of HBV gene amplicon after competitive PCR

Liquid-phase Hybridization in Polymerase Chain Reaction-Enzyme Linked Immunosorbent Assay

Multiplex Locked Nucleic Acid Probes for Analysis of Hepatitis B Virus Mutants Using Real-Time PCR

Novel Assay of Competitively Differentiated Polymerase Chain Reaction for Screening Point Mutation of Hepatitis B Virus.

Hybridization Assay of Hepatitis B Virus by QCM Peptide Nucleic Acid Biosensor.

Determination of PCR Product by Bioluminescence

Sequence-encoded Quantitative Invader Assay Enables Highly Sensitive Hepatitis B Virus DNA Quantification in a Single Tube Without the Use of a Calibration Curve.

Analytical performance of and real sample analysis with an HBV gene visual detection chip.

Microarrays for Detecting HBV and HDV

Instantaneous derivatization technology for the simultaneous and homogeneous detection of multiple double-stranded PCR amplicons.

A sensitive and accurate quantification method for the detection of hepatitis B virus covalently closed circular DNA by the application of a droplet digital polymerase chain reaction amplification system

A quantitative method to detect HBV cccDNA by chimeric primer and real-time polymerase chain reaction.

A molecular detection method for HBV pgRNA without RNA extraction based on nucleic acid hybridization

The Application of Alkaline Phosphatase Labeled HBV Probe in Serum Detection

Detection of Hepatitis C Virus RNA by Coated Microtiter Plate Hybridization

[Applying Competitive Polymerase Chain Reaction to the Detection of Hepatitis B Virus DNA].

Real-Time PCR Assay Using Molecular Beacon for Quantitation of Hepatitis B Virus DNA

An isothermal amplification system based on the tandem-repeated DNA probe

Amplification of Complete Hepatitis B Virus Genome by a Sensitive Nested PCR

CRISPR/Cas12b assisted loop-mediated isothermal amplification for easy, rapid and sensitive quantification of chronic HBV DNA in one-pot

A New and Sensitive Method for the Quantification of HBV Cccdna by Real-Time PCR